Corient Capital Partners, LLC Boston Scientific Corp Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Corient Capital Partners, LLC holds 15,947 shares of BSX stock, worth $1.61 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
15,947
Previous 15,947
-0.0%
Holding current value
$1.61 Million
Previous $594,000
-0.0%
% of portfolio
0.04%
Previous 0.05%
Shares
15 transactions
Others Institutions Holding BSX
# of Institutions
1,673Shares Held
1.18BCall Options Held
8.76MPut Options Held
9.42M-
Vanguard Group Inc Valley Forge, PA133MShares$13.4 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY126MShares$12.8 Billion0.22% of portfolio
-
State Street Corp Boston, MA64MShares$6.45 Billion0.23% of portfolio
-
Primecap Management CO Pasadena, CA36.9MShares$3.73 Billion2.61% of portfolio
-
Geode Capital Management, LLC Boston, MA30.6MShares$3.09 Billion0.22% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $144B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...